Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D B Calne

Showing results (221-230 of 315) with videos related to

Pageof 32
Sort By:
Parkinsonism & Related Disorders|March 6, 2003
Familial and sporadic Parkinson's disease usually display the same clinical featuresJ Carr, R de la Fuente-Fernández, M Schulzer, et al.
Neurology|July 1, 1983
Parkinson's disease in 65 pairs of twins and in a set of quadrupletsC D Ward, R C Duvoisin, S E Ince, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 1995
Screening Parkinson's disease: a validated questionnaire of high specificity and sensitivityJ Duarte, L E Clavería, J de Pedro-Cuesta, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 16, 2000
Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonismB J Snow, F J Vingerhoets, J W Langston, et al.
British Journal of Clinical Pharmacology|January 6, 2012
The cardiovascular effects of bromocriptine in ParkinsonismJ K Greenacre, P F Teychenne, A Petrie, et al.
Parkinsonism & Related Disorders|July 1, 1995
Neurodegenerative 'overlap' syndrome: Clinical and pathological features of Parkinson's disease, motor neuron disease, and Alzheimer's diseaseR J Uitti, K Berry, O Yasuhara, et al.
Annals of Neurology|November 1, 1994
Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesionsF J Vingerhoets, B J Snow, J W Tetrud, et al.
Neurology|May 1, 1990
Decreased efficacy of levodopa with carbidopa in parkinsonian patients after adrenal-to-caudate implantsJ K Tsui, R F Peppard, K C Petruk, et al.
Annals of Neurology|October 1, 1990
Treatment of spasticity with botulinum toxin: a double-blind studyB J Snow, J K Tsui, M H Bhatt, et al.
Annals of Neurology|March 1, 1994
Biochemical and fluorodopa positron emission tomographic findings in an asymptomatic carrier of the gene for dopa-responsive dystoniaH Takahashi, R A Levine, M P Galloway, et al.
Pageof 32

Showing results (221-230 of 315) with videos related to

Sort By:
Pageof 32
Parkinsonism & Related Disorders|March 6, 2003
Familial and sporadic Parkinson's disease usually display the same clinical featuresJ Carr, R de la Fuente-Fernández, M Schulzer, et al.
Neurology|July 1, 1983
Parkinson's disease in 65 pairs of twins and in a set of quadrupletsC D Ward, R C Duvoisin, S E Ince, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 1995
Screening Parkinson's disease: a validated questionnaire of high specificity and sensitivityJ Duarte, L E Clavería, J de Pedro-Cuesta, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 16, 2000
Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonismB J Snow, F J Vingerhoets, J W Langston, et al.
British Journal of Clinical Pharmacology|January 6, 2012
The cardiovascular effects of bromocriptine in ParkinsonismJ K Greenacre, P F Teychenne, A Petrie, et al.
Parkinsonism & Related Disorders|July 1, 1995
Neurodegenerative 'overlap' syndrome: Clinical and pathological features of Parkinson's disease, motor neuron disease, and Alzheimer's diseaseR J Uitti, K Berry, O Yasuhara, et al.
Annals of Neurology|November 1, 1994
Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesionsF J Vingerhoets, B J Snow, J W Tetrud, et al.
Neurology|May 1, 1990
Decreased efficacy of levodopa with carbidopa in parkinsonian patients after adrenal-to-caudate implantsJ K Tsui, R F Peppard, K C Petruk, et al.
Annals of Neurology|October 1, 1990
Treatment of spasticity with botulinum toxin: a double-blind studyB J Snow, J K Tsui, M H Bhatt, et al.
Annals of Neurology|March 1, 1994
Biochemical and fluorodopa positron emission tomographic findings in an asymptomatic carrier of the gene for dopa-responsive dystoniaH Takahashi, R A Levine, M P Galloway, et al.
Pageof 32